SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-21-004499
Filing Date
2021-10-13
Accepted
2021-10-13 17:36:39
Documents
1
Period of Report
2021-10-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 14736
  Complete submission text file 0000902664-21-004499.txt   16758
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Issuer) CIK: 0001504776 (see all company filings)

IRS No.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods
Office of Life Sciences

Mailing Address C/O D1 CAPITAL PARTNERS L.P. 9 WEST 57TH STREET, 36TH FLOOR NEW YORK NY 10019
Business Address
Sundheim Daniel S. (Reporting) CIK: 0001621588 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40825 | Film No.: 211322006

Mailing Address 9 WEST 57TH STREET 36TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 36TH FLOOR NEW YORK NY 10019 (212) 390-9100
D1 Capital Partners L.P. (Reporting) CIK: 0001747057 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40825 | Film No.: 211322007